On January 20th, 2021 PANCAIM project (Pancreatic cancer AI for genomics and personalized Medicine) was officially kicked-off via online conferencing service where all partners from 9 organizations participated. The project is coordinated by Radboud University Medical Centre Nijmegen from Netherlands, with the participation of Karolinska Institutet (Sweden), Oslo universitetssykehus HF (Norway), Spanish National Cancer Research Center (Spain), University of Glasgow (UK), Collective Minds Radiology (Sweden), Siemens Healthineers (Germany), The Hyve (Netherlands ) and Amires (Czech Republic).

PANCAIM will develop trusted impactful AI applications for regular clinical use to help clinical decision-makers to give the right treatment to the right patients at the right time, and at the right cost and improve treatment outcomes of PDAC patients.